Pregnancy Triggers Breast Immune Cells That May Help Suppress Cancer, Study Finds
While women who have gone through pregnancy and childbirth are known to carry a lower long-term risk of developing breast cancer, scientists have...
Search results for "tumor"
Novartis to Buy UK Biotech Myricx for Up to $1.5 Billion, Boosting ADC Portfolio
Novartis is significantly expanding its oncology portfolio after securing an antibody-drug conjugate technology designed to deliver potent anticancer...
Qurient’s Mocaciclib Opens New Combination Frontiers for Hard-to-Treat Breast Cancer
Qurient announced on June 29 that it presented key clinical data highlighting the mechanistic advantages of its...
Born to Age Faster? How Accelerated Biological Aging Drives Rising Cancer Risk in Younger Generations
As cancer incidence inexplicably rises among younger adults worldwide, a pivotal new study suggests an unsettling...
Muscle Loss Double-Whammy: Sarcopenia Triggers Faster Progression in Lung Cancer Patients on Immunotherapy
Muscle mass in lung cancer patients may play a decisive role in determining the success of immunotherapy.
When High Blood Sugar Won’t Go Away: The Overlooked Warning Sign of Pancreatic Cancer
Pancreatic cancer is notoriously difficult to detect in its early stages because symptoms typically manifest late in...
When Other Biologics Fail: Skyrizi Drives Steroid-Free Remission in Over Half of Hard-to-Treat Crohn’s Patients
Crohn’s disease remains one of the most challenging inflammatory bowel diseases to manage.
Mapping Cancer’s Footprint: Specialized PET/CT Scans Pinpoint Metastasis and Recurrence
Following a cancer diagnosis, patients and their families almost invariably ask the same urgent question: “How far has...
From Bludgeon to Scalpel: ASCO 2026 Signals Oncology’s Shift From ‘Strong Chemo’ to ‘Right Chemo’
The standard of care in cancer treatment is undergoing a rapid paradigm shift. For decades, the default oncological...
MSD Bets $510M on High-Quality Data to Fuel Post-Keytruda AI Drug Discovery
MSD, which has long dominated the global cancer market with its blockbuster immuno-oncology therapy Keytruda, is...